Blame LABA Risks in Asthma on Gene Variants?

January 28, 2014 7:01 PM

14 0

Rare genetic variants may explain the equally uncommon but life-threatening adverse events seen with long-acting beta agonist (LABA) drugs in asthma, a study suggested.

Two of those rare variants were also associated with asthma exacerbations requiring urgent outpatient healthcare visits and poor symptom control on LABA therapy, Eugene R. Bleecker, MD, director of the Wake Forest Center for Genomics and Personalized Medicine in Winston-Salem, N.C., and colleagues f...

Read more

To category page